Monday, December 23, 2024
HomeTagsJean-Louis Saillot

Jean-Louis Saillot

Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-004

Inmagene Biopharmaceutical ("Inmagene") and HUTCHMED (China) Limited ("HUTCHMED") announce that the first participant, based in the United States, was dosed in a global Phase...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics